The role of filaggrin in the skin barrier and disease development;Filagrina: papel en la barrera cutánea y en el desarrollo de patología

Actas Dermo-Sifiliograficas

Volumn 106, Issue 2, 2015, Pages 86-95

  Armengot Carbo, M ^a   Hernandez Martin A ^a   Torrelo, A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Allergic rhinitis; Asthma; Atopic dermatitis; Epidermis; Filaggrin; Ichthyosis vulgaris

Indexed keywords

FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN;

ARTICLE; ATOPIC DERMATITIS; ATOPY; DISEASE EXACERBATION; FILAGGRIN GENE; GENE; GENE MUTATION; ICHTHYOSIS VULGARIS; SKIN PERMEABILITY; ALLERGIC RHINITIS; ASTHMA; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; EPIGENETICS; FOOD ALLERGY; GENETIC ANALYSIS; HUMAN; IMMUNE SYSTEM; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; RISK ASSESSMENT; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; TH2 CELL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; MUTATION; PHYSIOLOGY; SKIN DISEASES;

HUMANS; INTERMEDIATE FILAMENT PROTEINS; MUTATION; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 84923606346     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2014.12.007     Document Type: Short Survey

References (101)

1. K.C. Madison Barrier function of the skin: «la raison d'être» of the epidermis J Invest Dermatol 121 2003 231 241
2. A. Sandilands, C. Sutherland, A.D. Irvine, and W.H. McLean Filaggrin in the frontline: Role in skin barrier function and disease J Cell Sci 122 2009 1285 1294
3. B.A. Dale Purification and characterization of a basic protein from the stratum corneum of mammalian epidermis Biochim Biophys Acta 491 1977 193 204
4. P.M. Steinert, J.S. Cantieri, D.C. Teller, J.D. Lonsdale-Eccles, and B.A. Dale Characterization of a class of cationic proteins that specifically interact with intermediate filaments Proc Natl Acad Sci USA 78 1981 4097 4101
5. M.A. McAleer, and A.D. Irvine The multifunctional role of filaggrin in allergic skin disease J Allergy Clin Immunol 131 2013 280 291
6. E. Proksch, J.M. Brandner, and J.-M. Jensen The skin: An indispensable barrier Exp Dermatol 17 2008 1063 1072
7. Z. Nemes, and P.M. Steinert Bricks and mortar of the epidermal barrier Exp Mol Med 31 1999 5 19
8. G.K. Menon, S. Grayson, and P.M. Elias Ionic calcium reservoirs in mammalian epidermis: Ultrastructural localization by ion-capture cytochemistry J Invest Dermatol 84 1985 508 512
9. S.H. Lee, P.M. Elias, E. Proksch, G.K. Menon, M. Mao-Quiang, and K.R. Feingold Calcium and potassium are important regulators of barrier homeostasis in murine epidermis J Clin Invest 89 1992 530 538
10. J. Heimall, and J.M. Spergel Filaggrin mutations and atopy: Consequences for future therapeutics Expert Rev Clin Immunol 8 2012 189 197
11. A. Kalinin, L.N. Marekov, and P.M. Steinert Assembly of the epidermal cornified cell envelope J Cell Sci 114 2001 3069 3070
12. A.E. Kalinin, A.V. Kajava, and P.M. Steinert Epithelial barrier function: Assembly and structural features of the cornified cell envelope Bioessays 24 2002 789 800
13. E. Candi, R. Schmidt, and G. Melino The cornified envelope: A model of cell death in the skin Nat Rev Mol Cell Biol 6 2005 328 340
14. A.V. Rawlings, and C.R. Harding Moisturization and skin barrier function Dermatol Ther 17 Suppl 1 2004 43 48
15. S.J. Brown, and W.H. McLean One remarkable molecule: Filaggrin J Invest Dermatol 132 2012 751 762
16. R. Gruber, P.M. Elias, D. Crumrine, T.-K. Lin, J.M. Brandner, and J.-P. Hachem Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function Am J Pathol 178 2011 2252 2263
17. S.M. Ali, and G. Yosipovitch Skin pH: From basic science to basic skin care Acta Derm Venereol 93 2013 261 267
18. C. Barresi, C. Stremnitzer, V. Mlitz, S. Kezic, A. Kammeyer, and M. Ghannadan Increased sensitivity of histidinemic mice to UVB radiation suggests a crucial role of endogenous urocanic acid in photoprotection J Invest Dermatol 131 2011 188 194
19. F.P. Noonan, and E.C. de Fabo Immunosuppression by ultraviolet B radiation: Initiation by urocanic acid Immunol Today 13 1992 250 254
20. J.P. Walterscheid, D.X. Nghiem, N. Kazimi, L.K. Nutt, D.J. McConkey, and M. Norval Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor Proc Natl Acad Sci USA 103 2006 1742 1745
21. A.D. Irvine, W.H.I. McLean, and D.Y.M. Leung Filaggrin mutations associated with skin and allergic diseases N Engl J Med 365 2011 1315 1327
22. S. Kezic, G.M. O'Regan, R. Lutter, I. Jakasa, E.S. Koster, and S. Saunders Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency J Allergy Clin Immunol 129 2012 1031 1039 e1
23. D. Mischke, B.P. Korge, I. Marenholz, A. Volz, and A. Ziegler Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex («epidermal differentiation complex») on human chromosome 1q21 J Invest Dermatol 106 1996 989 992
24. R.B. Presland, P.V. Haydock, P. Fleckman, W. Nirunsuksiri, and B.A. Dale Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus J Biol Chem 267 1992 23772 23781
25. R.B. Presland, J.A. Bassuk, J.R. Kimball, and B.A. Dale Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin J Invest Dermatol 104 1995 218 223
26. S. Aho, C.R. Harding, J.M. Lee, H. Meldrum, and C.A. Bosko Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis J Invest Dermatol 132 2012 2376 2385
27. A. Ishida-Yamamoto, H. Takahashi, R.B. Presland, B.A. Dale, and H. Iizuka Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma Lab Invest 78 1998 1245 1253
28. K. Yoneda, T. Nakagawa, O.T. Lawrence, J. Huard, T. Demitsu, and Y. Kubota Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis J Invest Dermatol 132 2012 1206 1214
29. F.J.D. Smith, A.D. Irvine, A. Terron-Kwiatkowski, A. Sandilands, L.E. Campbell, and Y. Zhao Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris Nat Genet 38 2006 337 342
30. H. Chen, J.E. Common, R.L. Haines, A. Balakrishnan, S.J. Brown, and C.S. Goh Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations Br J Dermatol 165 2011 106 114
31. J.P. Thyssen, E. Godoy-Gijon, and P.M. Elias Ichthyosis vulgaris - the filaggrin mutation disease Br J Dermatol 2013
32. V. Mlitz, J. Latreille, S. Gardinier, R. Jdid, Y. Drouault, and P. Hufnagl Impact of filaggrin mutations on Raman spectra and biophysical properties of the stratum corneum in mild to moderate atopic dermatitis J Eur Acad Dermatol Venereol 26 2012 983 990
33. R. Cascella, V. Foti Cuzzola, T. Lepre, E. Galli, V. Moschese, and L. Chini Full sequencing of the FLG gene in Italian patients with atopic eczema: Evidence of new mutations, but lack of an association J Invest Dermatol 131 2011 982 984
34. M. Mildner, J. Jin, L. Eckhart, S. Kezic, F. Gruber, and C. Barresi Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model J Invest Dermatol 130 2010 2286 2294
35. J.P. Thyssen, B. Thuesen, C. Huth, M. Standl, C.G. Carson, and J. Heinrich Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations J Allergy Clin Immunol 130 2012 1204 1207 e2
36. V.P. Sybert, B.A. Dale, and K.A. Holbrook Ichthyosis vulgaris: Identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules J Invest Dermatol 84 1985 191 194
37. C. Katagiri, J. Sato, J. Nomura, and M. Denda Changes in environmental humidity affect the water-holding property of the stratum corneum and its free amino acid content, and the expression of filaggrin in the epidermis of hairless mice J Dermatol Sci 31 2003 29 35
38. J.P. Thyssen, K. Ross-Hansen, J.D. Johansen, C. Zachariae, B.C. Carlsen, and A. Linneberg Filaggrin loss-of-function mutation R501X and 22824 carrier status is associated with fissured skin on the hands: Results from a cross-sectional population study Br J Dermatol 166 2012 46 53
39. S.J. Brown, C.L. Relton, H. Liao, Y. Zhao, A. Sandilands, and I.J. Wilson Filaggrin null mutations and childhood atopic eczema: A population-based case-control study J Allergy Clin Immunol 121 2008 940 946 e3
40. A. De Benedetto, A. Kubo, and L.A. Beck Skin barrier disruption: A requirement for allergen sensitization? J Invest Dermatol 132 2012 949 963
41. S.G.O. Johansson, T. Bieber, R. Dahl, P.S. Friedmann, B.Q. Lanier, and R.F. Lockey Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 J Allergy Clin Immunol 113 2004 832 836
42. T. Zheng, J. Yu, M.H. Oh, and Z. Zhu The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma Allergy Asthma Immunol Res 3 2011 67 73
43. J.M. Spergel, and A.S. Paller Atopic dermatitis and the atopic march J Allergy Clin Immunol 112 2003 S118 S127
44. K.J. Allen, and S.C. Dharmage The role of food allergy in the atopic march Clin Exp Allergy 40 2010 1439 1441
45. C.N.A. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, and S.P. Lee Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
46. Y. Werner, and M. Lindberg Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis Acta Derm Venereol 65 1985 102 105
47. S. Seidenari, and G. Giusti Objective assessment of the skin of children affected by atopic dermatitis: A study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin Acta Derm Venereol 75 1995 429 433
48. S. Weidinger, E. Rodríguez, C. Stahl, S. Wagenpfeil, N. Klopp, and T. Illig Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis J Invest Dermatol 127 2007 724 726
49. P.G. Fallon, T. Sasaki, A. Sandilands, L.E. Campbell, S.P. Saunders, and N.E. Mangan A homozygous frameshift mutation in the mouse FLG gene facilitates enhanced percutaneous allergen priming Nat Genet 41 2009 602 608
50. M.K. Oyoshi, G.F. Murphy, and R.S. Geha Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen J Allergy Clin Immunol 124 2009 485 493 493.e1
51. H. Kawasaki, K. Nagao, A. Kubo, T. Hata, A. Shimizu, and H. Mizuno Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice J Allergy Clin Immunol 129 2012 1538 1546 e6
52. T. McPherson, V.J. Sherman, A. Aslam, L. Crack, H. Chan, and A. Lloyd-Lavery Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema Br J Dermatol 163 2010 544 549
53. T. Takai, and S. Ikeda Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases Allergol Int 60 2011 25 35
54. I. Marenholz, R. Nickel, F. Rüschendorf, F. Schulz, J. Esparza-Gordillo, and T. Kerscher Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march J Allergy Clin Immunol 118 2006 866 871
55. S. Weidinger, M. O'Sullivan, T. Illig, H. Baurecht, M. Depner, and E. Rodriguez Filaggrin mutations, atopic eczema, hay fever, and asthma in children J Allergy Clin Immunol 121 2008 1203 1209 e1
56. S.J. Brown, Y. Asai, H.J. Cordell, L.E. Campbell, Y. Zhao, and H. Liao Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy J Allergy Clin Immunol 127 2011 661 667
57. S. Ying, Q. Meng, C.J. Corrigan, and T.H. Lee Lack of filaggrin expression in the human bronchial mucosa J Allergy Clin Immunol 118 2006 1386 1388
58. A. De Benedetto, C.M. Qualia, F.M. Baroody, and L.A. Beck Filaggrin expression in oral, nasal, and esophageal mucosa J Invest Dermatol 128 2008 1594 1597
59. A. Wollenberg, and T. Bieber Proactive therapy of atopic dermatitis - an emerging concept Allergy 64 2009 276 278
60. A. Wollenberg, and L.M. Ehmann Long term treatment concepts and proactive therapy for atopic eczema Ann Dermatol 24 2012 253 260
61. G. Garnacho-Saucedo, R. Salido-Vallejo, and J.C. Moreno-Giménez Atopic dermatitis: Update and proposed management algorithm Actas Dermosifiliogr 104 2013 4 16
62. E. Rodríguez, H. Baurecht, E. Herberich, S. Wagenpfeil, S.J. Brown, and H.J. Cordell Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease J Allergy Clin Immunol 123 2009 1361 1370 e7
63. R.A. Van den Oord, and A. Sheikh Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: Systematic review and meta-analysis BMJ 339 2009 b2433
64. S.J. Brown, C.L. Relton, H. Liao, Y. Zhao, A. Sandilands, and W.H.I. McLean Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of: Further delineation of the skin phenotype in a prospective epidemiological study of 792 school children Br J Dermatol 161 2009 884 889
65. S.J. Brown, and W.H.I. McLean Eczema genetics: Current state of knowledge and future goals J Invest Dermatol 129 2009 543 552
66. S.J. Brown, A. Sandilands, Y. Zhao, H. Liao, C.L. Relton, and S.J. Meggitt Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema J Invest Dermatol 128 2008 1591 1594
67. S. Stemmler, Q. Parwez, E. Petrasch-Parwez, J.T. Epplen, and S. Hoffjan Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis J Invest Dermatol 127 2007 722 724
68. D.J. Margolis, A.J. Apter, J. Gupta, O. Hoffstad, M. Papadopoulos, and L.E. Campbell The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort J Allergy Clin Immunol 130 2012 912 917
69. J.M. Jungersted, H. Scheer, M. Mempel, H. Baurecht, L. Cifuentes, and J.K. Høgh Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema Allergy 65 2010 911 918
70. J. Henderson, K. Northstone, S.P. Lee, H. Liao, Y. Zhao, and M. Pembrey The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study J Allergy Clin Immunol 121 2008 872 877 e9
71. P.S. Gao, N.M. Rafaels, T. Hand, T. Murray, M. Boguniewicz, and T. Hata Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum J Allergy Clin Immunol 124 2009 507 513 513.e1-7
72. H. Bisgaard, A. Simpson, C.N.A. Palmer, K. Bønnelykke, I. McLean, and S. Mukhopadhyay Gene-environment interaction in the onset of eczema in infancy: Filaggrin loss-of-function mutations enhanced by neonatal cat exposure PLoS Med 5 2008 e131
73. M.L.A. Schuttelaar, M. Kerkhof, M.F. Jonkman, G.H. Koppelman, B. Brunekreef, and J.C. de Jongste Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure Allergy 64 2009 1758 1765
74. C. Cramer, E. Link, M. Horster, S. Koletzko, C.-P. Bauer, and D. Berdel Elder siblings enhance the effect of filaggrin mutations on childhood eczema: Results from the 2 birth cohort studies LISAplus and GINIplus J Allergy Clin Immunol 125 2010 1254 1260 e5
75. T. Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
76. R.E. Williams, A.G. Gibson, T.C. Aitchison, R. Lever, and R.M. Mackie Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis Br J Dermatol 123 1990 493 501
77. H. Miajlovic, P.G. Fallon, A.D. Irvine, and T.J. Foster Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus J Allergy Clin Immunol 126 2010 1184 1190 e3
78. K.O. Kisich, C.W. Carspecken, S. Fiéve, M. Boguniewicz, and D.Y. Leung Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3 J Allergy Clin Immunol 122 2008 62 68
79. A.M. Brauweiler, L. Bin, B.E. Kim, M.K. Oyoshi, R.S. Geha, and E. Goleva Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte death J Allergy Clin Immunol 131 2013 421 427 e2
80. S.C. Cai, H. Chen, W.P. Koh, J.E. Common, H.P. van Bever, and W.H. McLean Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis Br J Dermatol 166 2012 200 203
81. M.K. Oyoshi, R. He, L. Kumar, J. Yoon, and R.S. Geha Cellular and molecular mechanisms in atopic dermatitis Adv Immunol 102 2009 135 226
82. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, and A. de Benedetto Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 124 2009 R7 R12
83. B.E. Kim, D.Y.M. Leung, M. Boguniewicz, and M.D. Howell Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 Clin Immunol 126 2008 332 337
84. S.J. Brown, K. Kroboth, A. Sandilands, L.E. Campbell, E. Pohler, and S. Kezic Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect J Invest Dermatol 132 2012 98 104
85. A.H. Ziyab, W. Karmaus, J.W. Holloway, H. Zhang, S. Ewart, and S.H. Arshad DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants J Eur Acad Dermatol Venereol 27 2012 e420 e423
86. C.M. De Jongh, L. Khrenova, M.M. Verberk, F. Calkoen, F.J.H. van Dijk, and H. Voss Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: A case-control study Br J Dermatol 159 2008 621 627
87. M.J. Visser, L. Landeck, L.E. Campbell, W.H.I. McLean, S. Weidinger, and F. Calkoen Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis Br J Dermatol 168 2013 326 332
88. J.P. Thyssen, J.D. Johansen, A. Linneberg, T. Menné, N.H. Nielsen, and M. Meldgaard The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population Br J Dermatol 162 2010 1278 1285
89. K. Ross-Hansen, T. Menné, J.D. Johansen, B.C. Carlsen, A. Linneberg, and N.H. Nielsen Nickel reactivity and filaggrin null mutations - evaluation of the filaggrin bypass theory in a general population Contact Derm 64 2011 24 31
90. S. Molin, S. Vollmer, E.H. Weiss, T. Ruzicka, and J.C. Prinz Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis Br J Dermatol 161 2009 801 807
91. R.C. Betz, J. Pforr, A. Flaquer, S. Redler, S. Hanneken, and S. Eigelshoven Loss-of-function mutations in the filaggrin gene and alopecia areata: Strong risk factor for a severe course of disease in patients comorbid for atopic disease J Invest Dermatol 127 2007 2539 2543
92. H. Liao, A.J. Waters, D.R. Goudie, D.A. Aitken, G. Graham, and F.J.D. Smith Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis J Invest Dermatol 127 2007 2795 2798
93. R. Gruber, N.J. Wilson, F.J.D. Smith, D. Grabher, L. Steinwender, and P.O. Fritsch Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations Br J Dermatol 161 2009 1391 1395
94. J.P. Thyssen, A. Linneberg, B.C. Carlsen, J.D. Johansen, K. Engkilde, and T. Hansen A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: A cross-sectional study BMJ Open 1 2011 e000062
95. J.E.A. Common, S.J. Brown, R.L. Haines, C.S. Goh, H. Chen, and A. Balakrishnan Filaggrin null mutations are not a protective factor for acne vulgaris J Invest Dermatol 131 2011 1378 1380
96. Y. Zhao, A. Terron-Kwiatkowski, H. Liao, S.P. Lee, M.H. Allen, and P.R. Hull Filaggrin null alleles are not associated with psoriasis J Invest Dermatol 127 2007 1878 1882
97. J.P. Thyssen, J.D. Johansen, B.C. Carlsen, A. Linneberg, M. Meldgaard, and P.B. Szecsi The filaggrin null genotypes R501X and 22824 seem not to be associated with psoriasis: Results from general population study and meta-analysis J Eur Acad Dermatol Venereol 26 2012 782 784
98. U. Hüffmeier, U. Böiers, J. Lascorz, A. Reis, and H. Burkhardt Loss-of-function mutations in the filaggrin gene: No contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis Ann Rheum Dis 67 2008 131 133
99. J. Van Limbergen, R.K. Russell, E.R. Nimmo, Y. Zhao, H. Liao, and H.E. Drummond Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease Inflamm Bowel Dis 15 2009 1492 1498
100. A. Ruether, M. Stoll, T. Schwarz, S. Schreiber, and R. Fölster-Holst Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany Br J Dermatol 155 2006 1093 1094
101. S. Rodriguez, A.J. Hall, R. Granell, W.H. McLean, A.D. Irvine, and C.N. Palmer Carrier status for the common R501X and 22824 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort PLoS ONE 4 2009 e5784